This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Washington University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Tom Ellenberger: Innovator in Small Molecule PARG Inhibitors
Introduction
Tom Ellenberger is a distinguished inventor based in St. Louis, MO (US). He has made significant contributions to the field of biochemistry, particularly in the development of small molecule PARG inhibitors. His work is vital for advancing therapeutic methods in various medical applications.
Latest Patents
Ellenberger holds a patent for "Small Molecule PARG Inhibitors and Methods of Use Thereof." This patent represents a crucial step in the exploration of new treatments that target specific biological pathways. His innovative approach has the potential to impact the treatment of various diseases.
Career Highlights
Tom Ellenberger is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His career is marked by a commitment to scientific excellence and innovation. Ellenberger's work has garnered attention in the scientific community, showcasing his expertise and dedication.
Collaborations
Ellenberger has collaborated with notable colleagues, including John A. Tainer and Darin E. Jones. These partnerships have enriched his research and contributed to the advancement of their shared goals in the field of biochemistry.
Conclusion
Tom Ellenberger is a prominent figure in the realm of small molecule research, with a focus on PARG inhibitors. His contributions to science and collaboration with esteemed colleagues highlight his commitment to innovation and discovery.